Nanobiotix
is a France-based biotechnology company that researches, develops, and commercializes novel therapeutics for cancer treatment... Read moreNanobiotix
is a France-based biotechnology company that researches, develops, and commercializes novel therapeutics for cancer treatment... Read more
News
Jun 12, 2026
Sahmcapital
Nanobiotix: Nanobiotix says Goldman Sachs beneficial stake rises to 7.10% of capital, 6.66% voting rights
Jun 05, 2026
Marketminute
Nanobiotix: Articles from Nanobiotix S.A.
Jun 03, 2026
MarketScreener
Nanobiotix: Oddo BHF sees upside potential for Nanobiotix
Jun 03, 2026
Nasdaq
Nanobiotix: Nanobiotix Reports Q1 2026 Update; Expects Cash Runway Through 2029
Jun 02, 2026
Finanzwire
Nanobiotix: Nanobiotix joins the Euronext Tech Leaders index
Jun 02, 2026
Advfn
Nanobiotix: Nanobiotix Provides First Quarter 2026 Operational and Financial Update
Jun 02, 2026
Briefglance
Nanobiotix: Nanobiotix Joins Elite Index, Validating Physics-Based Cancer Fight
May 26, 2026
Nasdaq
Nanobiotix: Nanobiotix Exercises Underwriters' Option In Global Offering, Gross Proceeds Reach $100 Mln
May 21, 2026
MarketScreener
Nanobiotix: Nanobiotix raises 85 million euros
May 21, 2026
Wytv
Nanobiotix: Nanobiotix Announces Pricing of Oversubscribed 85m Global Offering
Nanobiotix Competitors
1
2
3
4
5
6
7
8
9
10